Mr. Philippe Dubuc reports

THERATECHNOLOGIES TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE

Theratechnologies Inc. will release financial results and provide a business update for its first quarter ended Feb. 29, 2024, on Wednesday, April 10, 2024, at 8:30 a.m. ET.

The call will be hosted by Paul Levesque, president and chief executive officer. Mr. Levesque will be joined by other members of the management team, including Philippe Dubuc, senior vice-president and chief financial officer, Dr. Christian Marsolais, PhD, senior vice-president and chief medical officer, and John Leasure, global commercial officer, who will be available to answer questions from participants following prepared remarks.

Participants are encouraged to join the call at least 10 minutes in advance to secure access.

Conference call information

Conference call date:  April 10, 2024

Conference call time:  8:30 a.m. ET

Dial-in numbers:  1-888-513-4119 (toll-free) or 1-412-902-6615 (international)

Access code:  4991919

Conference call replay

Toll-free:  1-877-344-7529 (United States) or 1-855-669-9658 (Canada)

International toll:  1-412-317-0088

Replay access code:  3783831

Replay end date:  April 17, 2024

An archived webcast will also be available on the company's investor relations website.

About Theratechnologies Inc.

Theratechnologies is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs.